Mean serum lipid levels in Iranian adult populations: a systematic review and meta-analysis

Q Medicine Clinical Lipidology Pub Date : 2015-10-01 DOI:10.2217/clp.15.30

M. Qorbani, Ozra Tabatabaei-Malazy, R. Kelishadi, B. Larijani

引用次数: 4

Abstract

Abstract Background: Dyslipidemia has large variations in populations. This systematic review, meta-analysis study assessed mean lipid profiles in Iran. Methods: We extracted data from all relevant published population-based studies or national surveys conducted in adults up to January 2014. Studies with <300 individuals, or in specific group diseases were excluded. Data were analyzed by random effect method. Results: Mean and 95% CI of total cholesterol (T-C), triglycerides (TG), LDL-cholesterol, and HDL-cholesterol (LDL-C and HDL-C) in 27 eligible articles were estimated 195.7 (192.3–199.1), 169.8 (161.5–178.1), 120.5 (115.6–125.3) and 45.4 (43.2–47.6) mg/dl, respectively, among both sexes. Mean level of T-C, LDL-C and HDL-C in women were higher than men. Conclusion: Our findings are useful for international comparisons and planning national preventive programs.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

伊朗成年人平均血脂水平:系统回顾和荟萃分析

背景:血脂异常在人群中有很大的差异。这项系统回顾、荟萃分析研究评估了伊朗的平均脂质谱。方法:我们从截至2014年1月的所有相关已发表的基于人群的研究或全国成人调查中提取数据。<300人或特定群体疾病的研究被排除在外。采用随机效应法对数据进行分析。结果:27篇符合条件的文章中，总胆固醇(T-C)、甘油三酯(TG)、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇(LDL-C和HDL-C)的平均CI和95% CI估计分别为195.7(192.3-199.1)、169.8(161.5-178.1)、120.5(115.6-125.3)和45.4 (43.2-47.6)mg/dl。女性的T-C、LDL-C和HDL-C平均水平高于男性。结论:我们的研究结果对国际比较和制定国家预防方案有用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Clinical Lipidology 生物-生化与分子生物学

CiteScore

0.44

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The Journal of Clinical Lipidology is published to support the diverse array of medical professionals who work to reduce the incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism. The Journal''s readership encompasses a broad cross-section of the medical community, including cardiologists, endocrinologists, and primary care physicians, as well as those involved in the treatment of such disorders as diabetes, hypertension, and obesity. The Journal also addresses allied health professionals who treat the patient base described above, such as pharmacists, nurse practitioners and dietitians. Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.